New York, April 08, 2021 (GLOBE NEWSWIRE) -- Market Size USD 523.5 million in 2020, Market Growth at a CAGR of 7.5%, Market Trends The rapidly growing demand for biologics & biosimilars
The global solvent evaporation market size is expected to reach USD 926.8 million by 2028 at a CAGR of 7.5%, according to a new report by Reports and Data. The rising number of pharmaceutical and biopharmaceutical companies globally, rising government funds for pharmaceutical R&D activities, increasing collaborations among leading pharmaceutical companies and academic & research institutes, and the fast-paced adoption of laboratory automation solutions are among the most significant parameters contributing to the global solvent evaporation market development. The market has gained momentum over the last few years due to the rising prevalence of acute and chronic diseases, higher emphasis on new drug development, and the increasing number of clinical and research laboratories worldwide. The expanding biologics & biosimilars sector, growing demand for advanced cancer therapeutics, increasing adoption of large-molecule biopharmaceuticals, and the amplifying need for pure pharmaceutical drug samples create more opportunities for market growth in the near future.
Request free sample of solvent evaporation market report at: